Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127306301 | 12730630 | 1 | I | 20160829 | 20160910 | 20160910 | EXP | US-UCBSA-2016034382 | UCB | 0.00 | F | Y | 0.00000 | 20160910 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127306301 | 12730630 | 1 | PS | KEPPRA | LEVETIRACETAM | 1 | UNK | U | U | 21035 | FILM-COATED TABLET | ||||||||
| 127306301 | 12730630 | 2 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | Oral | 88 ?G, ONCE DAILY (QD) | U | 0 | 88 | UG | QD | ||||||
| 127306301 | 12730630 | 3 | C | DILTIAZEM HYDROCHLORIDE. | DILTIAZEM HYDROCHLORIDE | 1 | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127306301 | 12730630 | 1 | Product used for unknown indication |
| 127306301 | 12730630 | 2 | Hypothyroidism |
| 127306301 | 12730630 | 3 | Arterial spasm |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127306301 | 12730630 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127306301 | 12730630 | Generalised tonic-clonic seizure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127306301 | 12730630 | 2 | 2002 | 0 |